Acute Repetitive Seizures Market Will Grow Rapidly In Coming Years
Acute Repetitive Seizures Industry The global acute repetitive seizures market size is expected to reach USD 6.31 billion by 2030, according to a new report by Grand View Research, Inc. The report also states that the market will expand at a strong CAGR of 12.4% during the forecast period. Rise in the number of initiatives to increase awareness about epilepsy is the major factor driving the market. The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in the European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with a few major companies and a high market share. Furthermore, in an attempt to curb healthcare expenditure, governments are m...